menu ☰
menu ˟

New national contract for respiratory therapy

13 Oct 2016

The HSE has invited companies to compete for a new €10 million national contract for the provision of respiratory therapy products and services in the community being anticipated to be in place by the end of the first quarter of 2017, as part of the ongoing reform of Community-Funded Schemes (CFSs), Irish Medical Times reports.

The Executive late last year established a national reform programme to review all aspects of service provision under the CFSs. This programme has the aim of improving the quality and sustainability of the various schemes through the establishment of national standards, equity of access, value for money, functional processes and a management system that ensures compliance with those standards and objectives.

The CFS Reform Group for Respiratory Therapy Products concluded that a consolidated service would be the most appropriate supply/service strategy to meet the needs of clients. This approach will facilitate the clients and their carers by providing one contact point for all information, servicing, replacement or advice in relation to the use of the equipment and services.

It will also assist the HSE achieve standardisation of ordering processes, response times, installation and servicing, information and training, needs assessment and management reporting for clients and clinicians/staff.

The Executive is now asking interested companies to submit Expressions of Interest from which a shortlist will be drawn.

It is anticipated that existing HSE clients will be transferred to the new contracts, by geographical area, over an appropriate period with the objective of minimising the impact on clients and services.

According to the HSE, the national contract will be divided into two lots: Lot A — Ventilators, airway clearance and nebulisers, as well as associated consumables and monitoring equipment, with an estimated value of €1.7m per annum; and Lot B — Oxygen products and services, oxygen concentrators and associated consumables, with an estimated annual value of €8.1m.

Lloyd Mudiwa

Click here to view the full article which appeared in Irish Medical Times